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Fig. 1. Structure of curcumin.
In hepatic disorders, inflammatory cells such as macrophages gather around hepatic stellate (Kupffer) cells and discharge a variety of cytokines. During inflammation, proinflammatory cytokines and nitric oxide (NO), which is produced by inducible nitric oxide synthase (iNOS) in Kupffer cells and hepatocytes, play an important role as factors in liver injury [6] . However, NO exerts either detrimental or beneficial effects, depending on the insults and tissues involved.
In animal liver injury models caused by various insults, such as ischemia-reperfusion, partial hepatectomy, and endotoxin shock, we have previously reported that drugs [7] [8] [9] [10] [11] demonstrated how liver-protective effects inhibit induction of iNOS and NO production. These drugs also decrease production of various inflammatory mediators, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and cytokine-induced neutrophil chemoattractant (CINC)-1 (human IL-8 analogue) [7] [8] [9] [10] [11] .
We previously reported that in hepatocytes that were isolated by the collagen perfusion method from rats and cultured the proinflammatory cytokine IL-1β stimulated induction of iNOS gene expression in primary cultures of rat hepatocytes [12] . Previous studies on IL-1β-stimulated hepatocytes have shown that clinical drugs [9, 13, 14] as mentioned above also inhibit induction of iNOS and production of NO. Therefore, by using cultured hepatocytes, prevention of iNOS induction and NO production is considered to be one of the indicators of liver protection [15] .
In the present study, we examined IL-1β-stimulated hepatocytes and investigated the mechanisms underlying liver-protective effects of curcumin that are observed in various animal models. We examined whether curcumin affects induction of iNOS, and if so what mechanisms were involved in the action of curcumin.
MATERIALS AND METHODS:
Materials. Curcumin (Wako Pure Chemicals, Osaka, Japan) was dissolved in dimethyl sulfoxide (DMSO) at 100 mM and stored at −20ºC. The final concentration of DMSO in the culture medium was 0.1% or less. Recombinant human IL-1β (2 × 10 7 U/mg protein) was purchased from MyBioSource (San Diego, CA, USA). Male Wistar rats (200-250 g and 6-7 weeks old) were purchased from Charles River (Tokyo, Japan), kept at 22°C under a 12:12 h light:dark cycle, and received food and water ad libitum. All experiments on rats were performed in accordance with the Guidelines for the Care and Use of Laboratory Animals of the National Institutes of Health.
The experiments were approved by the Animal Care Committee of Kansai Medical University.
Primary cultures of hepatocytes. Hepatocytes were isolated from rats by perfusion with collagenase (Wako Pure Chemicals) [16] . Isolated hepatocytes were suspended in a culture medium at 6 × 10 5 cells/mL, seeded into 35-mm plastic dishes (2 mL/dish; Falcon Plastic, Oxnard, CA, USA), and cultured at 37°C in a CO2 incubator under a humidified atmosphere of 5% CO2 in air. The culture medium was WE supplemented with 10% newborn calf serum, 10 nM insulin, and 10 nM dexamethasone. After 5 h, the medium was replaced with fresh serum and hormone-free WE, and the cells were cultured overnight before use in experiments. The numbers of cells attached to the dishes were calculated by counting the number of nuclei [17] and using a ratio of 1.37 ± 0.04 nuclei/cell (mean ± SE, n = 7 experiments).
Treatment of cells with curcumin.
On day 1, the cells were washed with fresh serum-and hormone-free WE and incubated with IL-1β (1 nM) in the same medium in the presence or absence of curcumin. The doses of curcumin used are indicated in the appropriate figures and their legends.
Determination of NO production and lactate dehydrogenase (LDH) activity. Culture medium was used for measurements of nitrite (a stable metabolite of NO) to reflect NO production by the Griess method [18] . Culture medium was also used for measurements of LDH activity to reflect cell viability using a commercial kit (Roche Diagnostics, Mannheim, Germany).
Western blot analysis. Total cell lysates were obtained from cultured cells as described previously with minor modifications [13] . For Akt, total cell lysates prepared from 100-mm dishes (5 × 10 6 cells/dish) were pre-cleared with protein A (Sigma Chemical Co.) and then mixed with a mouse monoclonal antibody against human Akt1 (Akt5G3; Cell Signaling, Beverly, MA, USA) and protein G-Sepharose (Pharmacia LKB Biotech, Uppsala, Sweden). After incubation overnight at 4°C, immunocomplexes were centrifuged (16,000 × g for 5 min). The beads were washed with solubilizing buffer, dissolved in SDS-PAGE sample buffer, and analyzed by western blotting using rabbit polyclonal antibodies against human Akt and phospho-Akt (Ser473) (Cell Signaling) as primary antibodies. In the case of p65, nuclear extracts were immunoprecipitated with an anti-p65 antibody (H286; Santa Cruz Biotechnology). The bands were analyzed by western blotting using an antibody against human NF-κB p65 (BD Transduction Laboratories, Lexington, KY, USA).
Reverse transcriptase-polymerase chain reaction (RT-PCR). Total RNA was extracted from cultured hepatocytes using the guanidinium-phenol-chloroform method [19] . For strand-specific RT-PCR analysis, cDNA was synthesized from total RNA with strand-specific primers, and stepdown PCR was performed using PC708 (Astec, Fukuoka, Japan) as previously described [20] with minor modifications. For iNOS (257 bp), TNF-α (275 bp), CINC-1 (231 bp), IL-6 (286 bp), IL-1RI (327 bp), and elongation factor-1α (EF; internal control) (335 bp) mRNA, an oligo(dT) primer was used for RT and the indicated primers sets were used for PCR (Table 1) . For the antisense transcript of iNOS (211 bp), the sense primer (5'-TGCCCCTCCCCCACATTCTCT-3') was used for RT and the indicated primer set was used for PCR (Table 1) . These mRNAs and antisense transcript levels were measured by real-time PCR using the Rotor-Gene Q 2plex HRM (Qiagen, Tokyo, Japan). The Rotor-Gene SYBR Green PCR Kit (Qiagen) was included in the reaction mixture, and the following touchdown protocol was applied: 1 cycle at 95°C for 5 min and 45 cycles at 95°C for 5 s and 60°C for 10 s. The cDNAs for the rat iNOS mRNA and antisense transcript were deposited in the DNA Data Bank of Japan/European Bioinformatics Institute (DDBJ/EMBL)/GenBank under the accession numbers AB250951 and AB250952 respectively.
Electrophoretic mobility shift assay. Nuclear extracts were prepared and an electrophoretic mobility shift assay was performed as previously described [21] . Briefly, nuclear extracts from hepatocytes (4 μg) were mixed with 1 μg of poly(dI-dC) and a probe for 20 min at room temperature (total mixture, 15 μl). To prepare a double-stranded DNA probe, annealed oligonucleotides harboring a κB site (5'-AGTTGAGGGGACTTTCCCAGGC-3'; only the sense strand is shown) were labelled with [γ-32 P]-adenosine-5′-triphosphate (ATP; DuPont-New England Nuclear Japan, Tokyo, Japan) and T4 polynucleotide kinase (Takara Bio Inc., Shiga, Japan). Samples were resolved on a 4.8% polyacrylamide gel, followed by drying and autoradiography. Protein concentrations were measured by the method of Bradford [22] with a binding assay kit (Bio-Rad) using bovine serum albumin as a standard.
Transfection and luciferase assay. Transfection of cultured hepatocytes was performed as previously described [23] . Briefly, hepatocytes were cultured at 4 × 10 5 cells/dish (35 × 10 mm) in WE supplemented with serum, dexamethasone, and insulin for 7 h before being subjected to magnet-assisted transfection (MATra). The reporter plasmid pRiNOS-Luc-SVpA or pRiNOSLuc-3′UTR (1 μg) and the CMV promoter-driven β-galactosidase plasmid pCMV-LacZ (1 ng) as an internal control were mixed with MATra-A reagent (1 μl; IBA GmbH, Göttingen, Germany).
After incubation for 15 min on a magnetic plate at room temperature, the medium was replaced with fresh WE containing serum. Cells were cultured overnight, and then treated with IL-1β in the presence or absence of curcumin. Luciferase and β-galactosidase activities of cell extracts were measured using PicaGene (Wako Pure Chemicals) and Beta-Glo (Promega, Wisconsin, USA) kits respectively.
Statistical analysis.
The results shown are representative of three to four independent experiments yielding similar findings. All data are expressed as means ± SD. Differences were analyzed by the Bonferroni-Dunn test, and a value of P < 0.05 was considered to indicate a significant difference. 
RESULTS:
Curcumin inhibits NO production and iNOS induction in IL-1β-stimulated hepatocytes. The proinflammatory cytokine IL-1β stimulated induction of iNOS, which was followed by production of NO in primary cultured rat hepatocytes. Simultaneous addition of curcumin and IL-1β reduced the levels of nitrite (a stable metabolite of NO) time and dose-dependently in the culture medium ( Fig. 2A and 2B ). Curcumin showed more than 90% inhibition at 25 µM. Curcumin had no cellular cytotoxicity with the various concentrations, as evaluated by the release of LDH into the culture medium ( Fig. 3) and Trypan blue exclusion by hepatocytes (data not shown).
Western blotting analysis showed that curcumin dose-dependently reduced the expression of the iNOS protein, showing its maximal effect at 25 µM (Fig. 2B) . RT-PCR analysis showed that curcumin decreased the expression of iNOS mRNA time-dependently ( Curcumin affects mRNA expression of proinflammatory cytokines. The expression of other mRNAs was examined. IL-1β increased the level of proinflammatory cytokine expression, by increasing TNF-α, CINC-1, and IL-6 mRNA levels, and curcumin decreased TNF-α, CINC-1, and IL-6 mRNA levels (Fig. 4) . Curcumin decreases iNOS mRNA synthesis and stabilization. We examined the mechanisms that are involved in inhibiting iNOS induction. Expression of iNOS mRNA is regulated by iNOS promoter transactivation with transcription factors, such as NF-κB, and by post-transcriptional modifications, such as mRNA stabilization [24] . Therefore, we carried out transfection experiments with constructs containing firefly luciferase controlled by the iNOS promoter (pRiNOS-Luc-SVpA and pRiNOS-Luc-3′UTR) (Fig. 5A) , which detects iNOS promoter transactivation (mRNA synthesis) and mRNA stabilization respectively. IL-1β increased the luciferase activity of these constructs, and these effects were significantly inhibited by curcumin ( Fig. 5B and 5C ). Furthermore, iNOS antisense transcript (asRNA) analysis by real-time RT-PCR showed that IL-1β increased the expression of iNOS asRNA in a time-dependent manner, and that curcumin markedly inhibited this effect (Fig. 5D) . Curcumin inhibits activation of NF-κB and upregulation of IL-1RI. There are two essential signaling pathways for induction of iNOS, called the IκB kinase and phosphatidylinositol 3-kinase (PI3K)/Akt pathways. In the former pathway, IL-1β stimulates degradation of IκB proteins after phosphorylation by IκB kinase, which is followed by activation of NF-κB (i.e., translocation from the cytoplasm to the nucleus and DNA binding). Curcumin had no effect on degradation of IκBα after IL-1β stimulation, but rather enhanced its degradation (Fig. 6A) . However, an electrophoretic mobility shift assay with nuclear extracts showed that curcumin inhibited NF-κB activation at 2-5 h, which indicated blockade of NF-κB nuclear translocation (Fig. 6B ).
In the PI3K/Akt pathway, IL-1β stimulates upregulation of IL-1RI by activation of PI3K/Akt [25, 26] . Immunoprecipitation-western blotting analysis showed that curcumin inhibited phosphorylation (activation) of Akt, a downstream kinase of PI3K (Fig. 7A) . Real-time RT-PCR and western blotting analyses revealed that curcumin reduced expression levels of IL-1RI mRNA and protein ( Fig. 7B and 7C ). were subjected to SDS-PAGE in a 7.5% gel, and immunoblotted with an anti-IL-1RI or anti-β-tubulin antibody.
Delayed administration of curcumin inhibits iNOS induction. We examined whether delayed administration of curcumin affects induction of iNOS. Curcumin was added to the medium 0-5 h after addition of IL-1β. Delayed administration of curcumin up to 2 h after IL-1β addition still markedly inhibited NO production, although the magnitude of inhibition decreased in a timedependent manner (Fig. 8) . 
DISCUSSION:
Curcumin is a pharmacologically safe compound with known anti-inflammatory, anticarcinogenic, and free radical scavenger properties [27] [28] [29] [30] [31] [32] . Curcumin supplementation in animal models results in an increase in several cytoprotective enzymes in liver and kidney tissues [33] [34] [35] . The antiinflammatory and antioxidant properties of curcumin have been well documented [36] [37] [38] .
However, the way in which these inhibitory responses are modulated by curcumin is still unclear [39] .
In this study, we found that curcumin inhibited induction of iNOS, and even TNF-α and IL-6
in IL-1β-stimulated hepatocytes. This finding indicates that curcumin may have anti-inflammatory effects in the liver. Intervention in NF-κB activation may also be beneficial in suppressing toxic/septic shock, graft versus host reactions, radiation damage, and inflammatory reactions. NF-κB plays a major role in inflammation by regulating genes encoding iNOS and proinflammatory cytokines, such as TNF-α [40] . Induction of iNOS gene expression is regulated by iNOS promoter transactivation and by post-transcriptional modifications [24] . Curcumin was recently reported to inhibit NOS [41, 42] . Ex vivo studies have suggested that the inducibility of NOS activity in macrophages is inhibited by 1-20-μM concentrations of curcumin [43] . Additionally, administration of an aqueous alkaline solution of curcumin in drinking water significantly inhibits murine hepatic lipopolysaccharide-induced iNOS gene expression [44] .
Curcumin also displays anticarcinogenic properties in animals as indicated by its ability to inhibit initiation of tumors when induced by phorbol esters [33, 34] , which are known to activate NF-κB. Because inhibiting NF-κB activity may represent a mechanism of intervention during carcinogenesis, curcumin's activity could have considerable implications for chemoprevention of cancer. NF-κB typically exists in the form of p50/65 heterodimers that are attached to its inhibitory proteins (IκBs, IκBα, and IκBβ) in the cytoplasm of cells. Activation of NF-κB involves i)
proteolytic degradation of IκBs in the proteosome after phosphorylation by IκB kinase, ii)
translocation of NF-κB to the nucleus, and iii) its binding to the promoter κB site [45] . In our study, curcumin in primary cultured rat hepatocytes inhibited NF-κB activation (Fig. 6B) . We anticipated that curcumin would inhibit IκBα degradation, resulting in inhibition of NF-κB nuclear translocation as well as in ML-1a (a human myelomonoblastic leukemia cell line) [46] . However, curcumin did not inhibit IκBα degradation in this condition ( In concert with NF-κB activation, upregulation of IL-1RI by activation of PI3K/Akt is also essential for the induction of iNOS [26] . We found that curcumin decreased IL-1RI mRNA and protein expression ( Fig. 7B and 7C ) by inhibiting Akt phosphorylation (Fig. 7A) . In regards to the activation of Akt, we previously found that inchinkoto [48] , hochuekito [49] , saireito [50] , and genipin [51] inhibited phosphorylation of Akt. These compounds also decreased IL-1RI mRNA and protein expression, similar to curcumin. In contrast, dexamethasone [52] , adenosine [53] , and glutamic acid [54] inhibit upregulation of IL-1RI, but have no effects on phosphorylation of Akt.
Therefore, the mechanisms involved in a reduction of induction of IL-1RI by dexamethasone, adenosine, and glutamic acid are unclear in the present.
Furthermore, in our experiments with iNOS promoter constructs, curcumin was found to inhibit induction of iNOS at the mRNA synthesis and stabilization steps ( Fig. 5B and 5C ). With regards to iNOS mRNA stabilization, the 3'-UTR of iNOS mRNA in rats has six adenine/uracilrich elements (AREs). These AREs are associated with ARE-binding proteins, such as HuR and the heterogeneous nuclear ribonucleoprotein L/I (PTB), which serve to stabilize mRNA [55] .
Recently, we reported that asRNAs are often transcribed from many inducible genes, such as iNOS and TNF-α [56] . The iNOS asRNA interacts with and stabilizes iNOS mRNA [57, 58] . We have reported that drugs, such as FR183998 (Na + /H + exchanger inhibitor) [9, 10] , insulin-like growth factor-I [11] , edaravone (free radical scavenger) [14] , inchinkoto [48] , hochuekito [49] , saireito [50] , genipin [51] , glutamic acid [54] , and sivelestat [59] inhibit iNOS induction. This was achieved partly by suppressing iNOS asRNA production in animal models and/or primary cultured hepatocytes. In the current study, curcumin also decreased iNOS asRNA expression (Fig. 5D ).
These findings show that curcumin inhibits two essential signaling pathways, NF-κB activation and IL-1RI upregulation, in the induction of iNOS. Curcumin probably reduces iNOS mRNA expression by inhibition of mRNA synthesis and stabilization, leading to a reduction in iNOS protein and NO production.
Proinflammatory cytokines, such as TNF-α, IL-1β, and IL-6 play an important role in causing injury to multiple organs, in addition to the liver. Inflammation is a biological response that helps to maintain homeostasis, but excessive inflammation following excessive stress causes organ damage. In our in vitro model, we recently reported that IL-1β stimulated induction of TNF-α, parallel with the induction of iNOS [60] . In the current study, curcumin decreased TNF-α, CINC-1, and IL-6 mRNA expression (Fig. 4A, 4B, and 4C ). This finding suggested that curcumin could inhibit induction of inflammatory mediators (iNOS, TNF-α, CINC-1, and IL-6), which resulted in liver-protective effects.
In our study, delayed treatment with curcumin after addition of IL-1β caused a significant reduction in NO production and induction of iNOS ( curcumin by itself may be useful in treating and preventing some diseases, but fully establishing its potential will require further studies and clinical applications. Our simple in vitro experiment with cultured hepatocytes may be adequate for the screening of liver-protective drugs because it is rapid and inexpensive compared with in vivo animal models of liver injury.
